Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
Public ClinicalTrials.gov record NCT03664674. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
Study identification
- NCT ID
- NCT03664674
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 148 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 27, 2018 (Actual)
- Primary completion
- Dec 22, 2020 (Actual)
- Completion
- Dec 22, 2020 (Actual)
- Last update posted
- Dec 7, 2022
2018 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central California Clinical Research | Fresno | California | 93720 | — |
| University of Colorado School of Medicine | Aurora | Colorado | 80045 | — |
| Colorado ENT & Allergy | Colorado Springs | Colorado | 80909 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| Ear, Nose and Throat Associates of South Florida | Boynton Beach | Florida | 33426 | — |
| Ear Research Foundation | Sarasota | Florida | 34239 | — |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | — |
| Michigan Ear Institute | Farmington Hills | Michigan | 48334 | — |
| Saint Louis University | St Louis | Missouri | 63110 | — |
| Dent Neurologic Institute | Amherst | New York | 14226 | — |
| New York Eye and Ear Infirmary of Mount Sinai | New York | New York | 10003 | — |
| Charlotte Eye Ear Nose & Throat Associates, P.A. | Matthews | North Carolina | 28105 | — |
| Piedmont Ear, Nose, and Throat Associates, PA | Winston-Salem | North Carolina | 27103 | — |
| Medical University of South Carolina, Department of Otolaryngology | Charleston | South Carolina | 29425 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Intermountain Ear, Nose & Throat Specialists | Draper | Utah | 84020 | — |
| West Virginia University School of Medicine | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03664674, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 7, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03664674 live on ClinicalTrials.gov.